Literature DB >> 692625

Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis.

K Graze, I J Spiler, A H Tashjian, K E Melvin, S Cervi-Skinner, R F Gagel, H H Miller, H J Wolfe, R A DeLellis, L Leape, Z T Feldman, S Reichlin.   

Abstract

To detect familial medullary thyroid carcinoma in a premetastatic stage, we administered tests provocative of calcitonin secretion (infusion of calcium or pentagastrin or both) each year for seven years to members of a pedigree now numbering 107. Since 1970, 21 patients converted from normal to abnormal secretory responses (two separate tests in which calcitonin levels exceeded 0.58 ng per milliliter). Twenty of 21 glands removed showed C-cell hyperplasia, and eight of the 20 also showed foci of carcinoma. As compared to the 12 patients with tumors detected during the first year of screening, all of whom had bilateral carcinoma (seven of 12 with local metastases), later carcinomas were smaller (mean diameter of 0.2 vs. 0.8 cm), were unilateral (in all but two cases) and occurred in younger patients (mean age of 14.9 vs. 36.4 years), and none had detectable metastases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 692625     DOI: 10.1056/NEJM197811022991804

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  22 in total

1.  Ret-proto-oncogene analysis in medullary thyroid carcinoma.

Authors:  D A O'Keeffe; A D Hill; K Sheahan; F Ryan; D Barton; R J Fitzgerald; E W McDermott; N J O'Higgins
Journal:  Ir J Med Sci       Date:  1998 Oct-Dec       Impact factor: 1.568

2.  My, How Things Have Changed in Multiple Endocrine Neoplasia Type 2A!

Authors:  Elizabeth G Grubbs; Robert F Gagel
Journal:  J Clin Endocrinol Metab       Date:  2015-07       Impact factor: 5.958

3.  Prevalence of C-cell hyperplasia and medullary thyroid carcinoma in a consecutive series of pheochromocytoma patients.

Authors:  S Jansson; G Hansson; H Salander; G Stenström; L E Tisell
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

4.  Screening for familial medullary thyroid carcinoma: a review.

Authors:  B A Ponder
Journal:  J R Soc Med       Date:  1984-07       Impact factor: 5.344

Review 5.  Calcitonin: perspectives in current concepts.

Authors:  H J Wolfe
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

6.  Medullary carcinoma of the thyroid.

Authors:  J Lynn; O I Gamvros; S Taylor
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

7.  2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer.

Authors:  R Elisei; M Alevizaki; B Conte-Devolx; K Frank-Raue; V Leite; G R Williams
Journal:  Eur Thyroid J       Date:  2012-12-19

8.  Mucosal neuroma syndrome--a phenotype for malignancy.

Authors:  M P White; K M Goel; J M Connor; N A Coutts
Journal:  Arch Dis Child       Date:  1985-09       Impact factor: 3.791

9.  [Modern methods in localization of pheochromocytomas (author's transl)].

Authors:  U Cordes; B Braun; M Georgi; F Kümmerle; V Lenner; E Magin; T Philipp; J Beyer
Journal:  Klin Wochenschr       Date:  1979-11-15

Review 10.  Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma.

Authors:  Andreas Machens; Henning Dralle
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.